These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21784901)

  • 61. A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.
    Schena FP; Esposito P; Rossini M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947692
    [TBL] [Abstract][Full Text] [Related]  

  • 62. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dense deposit disease and the factor H H402 allele.
    Lau KK; Smith RJ; Kolbeck PC; Butani L
    Clin Exp Nephrol; 2008 Jun; 12(3):228-32. PubMed ID: 18224273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.
    Paixão-Cavalcante D; Hanson S; Botto M; Cook HT; Pickering MC
    Mol Immunol; 2009 Jun; 46(10):1942-50. PubMed ID: 19411110
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
    Alexander MP; Fervenza FC; De Vriese AS; Smith RJH; Nasr SH; Cornell LD; Herrera Hernandez LP; Zhang Y; Sethi S
    J Nephrol; 2016 Apr; 29(2):203-209. PubMed ID: 26187133
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
    Marinozzi MC; Chauvet S; Le Quintrec M; Mignotet M; Petitprez F; Legendre C; Cailliez M; Deschenes G; Fischbach M; Karras A; Nobili F; Pietrement C; Dragon-Durey MA; Fakhouri F; Roumenina LT; Fremeaux-Bacchi V
    Kidney Int; 2017 Nov; 92(5):1232-1241. PubMed ID: 28712854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complement dysregulation in glomerulonephritis.
    Kaartinen K; Safa A; Kotha S; Ratti G; Meri S
    Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC
    Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
    Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
    Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of C3 glomerulopathy with complement blockers.
    Vivarelli M; Emma F
    Semin Thromb Hemost; 2014 Jun; 40(4):472-7. PubMed ID: 24799307
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange.
    Krmar RT; Holtbäck U; Linné T; Berg UB; Celsi G; Söderberg MP; Wernerson A; Szakos A; Larsson S; Skattum L; Bárány P
    Clin Nephrol; 2011 Feb; 75 Suppl 1():4-10. PubMed ID: 21269585
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dense deposit disease in a child with febrile sore throat.
    Conti G; De Vivo D; Vitale A; Fede C; Santoro D
    Saudi J Kidney Dis Transpl; 2017; 28(4):925-928. PubMed ID: 28748900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy.
    Guo WY; Liu QZ; Zhu L; Li ZY; Meng SJ; Shi SF; Liu LJ; Lv JC; Hou P; Zhang H
    Am J Med Sci; 2018 Aug; 356(2):114-120. PubMed ID: 30219152
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
    Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P
    Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations.
    Sessa A; Battini G; Meroni M; Daidone G; Carnera I; Brambilla PL; Viganò G; Giordano F; Pallotti F; Torri Tarelli L; Calabresi L; Rolleri M; Bertolini S
    Nephron; 2001 Jul; 88(3):268-72. PubMed ID: 11423760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
    Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.